GLOBAL BLOOD THERAPEUTICS IN (GBT)

US37890U1088 - Common Stock

68.49  +0.01 (+0.01%)

After market: 68.49 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
234.86M194.75M123.80M2.10M0.00
Cost Of Goods
4.45M3.32M2.00M0.00N/A
Gross Profit
230.41M191.43M121.80M2.10MN/A
Operating Expenses
529.65M479.12M366.00M291.70M182.70M
Research and Development
227.10M212.13M155.10M174.60M131.30M
Selling, General, and Administrative Expenses
302.55M266.99M210.90M117.10M51.40M
Operating Income
-299.24M-287.69M-244.20M-289.60M-182.70M
Interest Income/Expense
-22.32M-14.75M-4.00M14.70M8.60M
Other Income/Expense
-62.00K-177.00K-400.00K-200.00K-100.00K
Non Recurring Items
N/A0.001.00M8.30MN/A
Income Before Taxes
-321.62M-302.61M-247.60M-266.80M-174.20M
Income Tax
N/A477.00KN/AN/AN/A
Net Income
-322.46M-303.09M-247.60M-266.80M-174.20M
EBITDA
-293.19M-281.78M-235.88M-280.99M-178.09M
 
Per Share Data
EPS Diluted Total Ops
-5.00-4.81-4.04-4.58-3.40
Non GAAP EPS
-5.01-4.82-4.03-4.68-3.41
 
Statistics
Gross Profit Margin
98.10%98.30%98.38%100.00%N/A
Profit Margin
-137.30%-155.63%-200.00%-12704.76%N/A
Operating Profit Margin
-127.41%-147.72%-197.25%-13790.48%N/A

All data in USD

Charts